Spruce Biosciences, Inc. (SPRB)
NASDAQ: SPRB · Real-Time Price · USD
55.17
-1.69 (-2.96%)
At close: Sep 15, 2026, 4:00 PM EDT
55.89
+0.73 (1.31%)
After-hours: Sep 15, 2026, 7:53 PM EDT
Spruce Biosciences Market Cap
Spruce Biosciences has a market cap or net worth of $158.54 million as of September 15, 2026. Its market cap has increased by 2,170.86% in one year.
Market Cap
158.54M
Enterprise Value
69.92M
1-Year Change
2,170.86%
Ranking
Category
Stock Price
$55.17
ChartMarket Cap Chart
Since October 9, 2020, Spruce Biosciences's market cap has decreased from $378.48M to $158.54M, a decrease of -58.11%. That is a compound annual growth rate of -13.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 158.54M | 70.04% |
| Dec 31, 2025 | 93.24M | 437.50% |
| Dec 31, 2024 | 17.35M | -85.46% |
| Dec 29, 2023 | 119.28M | 361.35% |
| Dec 30, 2022 | 25.86M | -75.29% |
| Dec 31, 2021 | 104.65M | -81.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 160.68M |
| Codexis | 160.43M |
| Humacyte | 157.68M |
| Corbus Pharmaceuticals Holdings | 157.05M |
| Molecular Partners AG | 156.35M |
| Immunic | 155.82M |
| Kazia Therapeutics | 153.34M |
| Jyong Biotech | 147.72M |